CHMP recommends QUVIVIQ in Europe as a new treatment for adult insomnia patients
February 25, 2022Medical Communications
The CHMP has adopted a positive opinion for the use of QUVIVIQ for the treatment of adult patients with insomnia. …
Plant-based COVID-19 vaccine approved
February 25, 2022Medical Communications
Medicago and GlaxoSmithKline (GSK) have announced the approval by Health Canada of COVIFENZ®, a COVID-19 vaccine manufactured in plants, with …
South Korea approves Pfizer vaccine for children aged 5-11
February 24, 2022Business Services
South Korea’s drug safety agency on authorised the use of Pfizer’s COVID-19 vaccine on 23 February, for children aged between …
CDC: some should wait longer for second COVID-19 vaccination
February 24, 2022Business Services
The CDC updated its vaccine guidance for COVID-19, recommending that some American over the age of 12 who have received …
New sickle cell treatment administered to first patients in England
February 24, 2022Business Services
Sickle cell patients have now begun receiving the first new treatment for the blood disorder in over 20 years. The …
NICE recommends GSK’s ZEJULA (niraparib) for ovarian cancer patients
February 24, 2022Business Services
NICE has issued a Final Appraisal Determination (FAD), recommending the use of ZEJULA (niraparib) on the NHS. Niraparib is recommended …
93% accuracy in new Alzheimer’s test, according to international study
February 23, 2022Research and Development
The Washington University School of Medicine in St Louis has developed a blood test for Alzheimer’s disease which has proved …
Extra blood test could help detect risk of death from heart attack
February 23, 2022Research and Development
Researchers say that an extra blood test on suspected heart-attack patients could determine if they are at high risk of …
FDA places gene therapy trial on hold
February 23, 2022Research and Development
Homology Medicines has shared that the FDA has placed its pheNIX gene therapy trial of HMI-102 in adults with phenylketonuria …
NICE recommends Albireo’s Bylvay (odevixibat) for all PFIC types
February 23, 2022Research and Development
NICE has issued guidance that recommends Bylvay (odevixibat) for the treatment of all types of progressive familial intrahepatic cholestasis (PFIC) …
FDA grants approval for expanded indication of heart failure sensor
February 22, 2022Manufacturing and Production
The FDA has granted approval for an expanded indication of Abbott’s CardioMEMS HF System, a small implantable sensor that can …
NovoBiome and Inserm begin collaboration into human intestinal physiology
February 22, 2022Manufacturing and Production
NovoBiome, a drug discovery company developing breakthrough Live Biotherapeutics Products, announced that it has signed a new collaboration with the …
UK to offer extra COVID-19 booster for over-75s and high risk in spring
February 22, 2022Manufacturing and Production
An additional booster dose will be offered to all adults over-75, as well as the most vulnerable over-12s, in the …
Apollo Therapeutics and King’s College London collaborate for translational biology and drug development
February 22, 2022Manufacturing and Production
Apollo Therapeutics has expanded its partnerships with world-leading UK research institutions, entering into a strategic collaboration with King’s College, London. …
CanSinoBIO’s Convidecia approved as heterologous COVID-19 booster in China
February 21, 2022Sales and Marketing
CanSino Biologics announced that its recombinant novel coronavirus vaccine has been approved by the Joint Prevention and Control Mechanism of …
FDA approval of first disease-modifying drug for treatment of rare lifelong anaemia
February 21, 2022Sales and Marketing
Agios Pharmaceuticals has announced the FDA approval of Pyrukynd (mitapivat), for the treatment of haemolytic anaemia in adults with pyruvate …
‘Historic’ results for breast cancer drug and promise for broader use
February 21, 2022Sales and Marketing
AstraZeneca has shared that its drug, Enhertu, has demonstrated meaningful survival improvements in patients with breast cancer, compared with physician’s …
FDA considers approving second COVID-19 booster jab
February 21, 2022Sales and Marketing
US health regulators are looking at authorising a potential fourth dose of a COVID-19 vaccine, as reported by the Wall …
Study shows antibiotics affect gut microbes of newborns
February 18, 2022Medical Communications
Researchers from the Universities of Edinburgh and Birmingham, with the Spaarne Hospital and University Medical Centre Utrecht, Netherlands, have conducted …
Pfizer and BioNTech Omicron vaccine delayed
February 18, 2022Medical Communications
The delivery of Pfizer and BioNTech SE’s vaccine, targeted specifically towards the Omicron COVID-19 variant has been delayed by several …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
